RecruitingCancer
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The investigators will recruit and enroll individuals that may have the KRAS-variant or other microRNA binding site mutations to join registry studies. The investigators will allow individuals to obtain their results through a physician at the completion of the studies. The investigators current focus is cancer and autoimmunity.
Sponsor: MiraKind
You may qualify if…
- ✓ Personal or family history of cancer
- ✓ Personal history of endometriosis, or autoimmunity
You may not qualify if…
- ✕ Younger than 18
- ✕ Non-english speaking and unable to understand and sign the consent
Where it's recruiting
California
Los Angeles
Source: ClinicalTrials.gov · NCT02253251 · last updated 2025-01-23